We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase I trial of anti-CS1 monoclonal antibody elotuzumab in combination with bortezomib in the treatment of relapsed/refractory multiple myeloma.
- Authors
Jakubowiak, Andrzej J; Benson, Don M; Bensinger, William; Siegel, David S D; Zimmerman, Todd M; Mohrbacher, Ann; Richardson, Paul G; Afar, Daniel E H; Singhal, Anil K; Anderson, Kenneth C
- Abstract
To evaluate the maximum-tolerated dose (MTD), safety, and efficacy of elotuzumab in combination with bortezomib in patients with relapsed or relapsed and refractory multiple myeloma (MM).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Vol 30, Issue 16, p1960
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2011.37.7069